4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-22-000128
Director sold 2,253 shares at $33.22 ($74,845)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krognes Steve E. Director | 2022-08-19 | Sale | −2,253 | $33.22 | $74,845 | 149,468 | D |
| Open-market sales · 2,253 sh · avg $33.22 · $74,845 | |||||||
Loading xslF345X03/wf-form4_166128765076444.xml…